SOUTH SAN FRANCISCO, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that members of the RAPT management team will participate in the following investor conferences in November:
- Guggenheim Healthcare Talks: 5th Annual I&I Conference – Fireside chat on Tuesday, November 7, 2023 at 3:10 p.m. ET
- UBS BioPharma Conference 2023 ...